A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting. The COSMiC Prospective Prostate Cancer Registry
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms COSMiC
- Sponsors Janssen Inc
- 07 Jun 2017 Biomarkers information updated
- 01 Jun 2017 Planned number of patients changed from 500 to 260.
- 18 Feb 2017 Results assessing urologists experience with abiraterone acetate in a real-world trial, presented at the 2017 Genitourinary Cancers Symposium.